Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements Of Changes In Cash Flows (Unaudited)

v3.22.1
Condensed Consolidated Statements Of Changes In Cash Flows (Unaudited) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Cash flows provided by (used in) operating activities:      
Net income (loss) $ (115,171) $ (9,310) $ (54,221)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 12,358 9,423 7,316
Loss on asset disposal 0 238 125
Impairment of long-lived asset 4,567 0 0
Equity-based compensation 36,511 3,427 14,662
Warrant liabilities 12,796 887 3,363
Amortization of revolver loan costs 358 0 0
Amortization, net on marketable securities 675 0 0
Changes in operating assets and liabilities:      
Accounts receivable (4,208) 201 (401)
Prepaid expenses and other assets (11,422) 1,103 (5,202)
Prepaid revenue share fee (4,798) 2,377 (1,469)
Accounts payable 1,451 404 (2,233)
Accrued liabilities 50,045 (1,753) 8,238
Deferred revenue 87,021 (19,797) 43,752
Deferred rent (476) 462 2,644
Net cash used provided by (used in) operating activities 69,707 (12,338) 16,574
Cash flows used in investing activities:      
Business combinations, net of cash acquired (75,834) 0 0
Purchases of marketable securities (987,966) (170,625) (101,071)
Sales of marketable securities 689,572 166,219 90,475
Issuance of loan 0 (250) 0
Purchases of property and equipment (28,148) (16,502) (14,682)
Capitalized intangible assets (822) (424) (502)
Net cash used in investing activities (403,198) (21,582) (25,780)
Cash flows provided by (used in) financing activities:      
IPO proceeds, net of underwriter fees and issuance costs 436,837 0 0
Repurchase of members’ equity (11,744) (210,339) (12,085)
Proceeds from issuance of members’ equity, net of issuance costs 80,277 147,942 192,442
Distribution to post-reorganization members (4,114) 0 0
Issuance of warrants 289 0 0
Proceeds from the exercise of warrants 2,575 0 0
Payment of revolver loan costs (718) (652) 0
Net cash provided by (used in) financing activities 503,402 (63,049) 180,357
Net increase (decrease) in cash, cash equivalents, and restricted cash 169,911 (96,969) 171,151
Cash, cash equivalents, and restricted cash, beginning of period 139,082 236,051 64,900
Net exchange differences on cash and cash equivalents, and restricted cash 133 0 0
Cash, cash equivalents, and restricted cash, end of period $ 309,126 $ 139,082 $ 236,051